Compounds for the Treatment of Metabolic Disorders
申请人:Barba Oscar
公开号:US20120077793A1
公开(公告)日:2012-03-29
The present invention is directed to therapeutic compounds which have activity as agonists of GPR119 and are useful for the treatment of metabolic disorders including type II diabetes.
本发明涉及具有GPR119激动剂活性的治疗化合物,用于治疗代谢性疾病,包括2型糖尿病。
[EN] COMPOUNDS FOR THE TREATMENT OF METABOLIC DISORDERS<br/>[FR] COMPOSÉS POUR LE TRAITEMENT DE TROUBLES MÉTABOLIQUES
申请人:PROSIDION LTD
公开号:WO2010103333A1
公开(公告)日:2010-09-16
The present invention is directed to therapeutic compounds which have activity as agonists of GPR119 and are useful for the treatment of metabolic disorders including type II diabetes (I).